Personalised mRNA: Can Manufacturing Keep Up?
14 October 2026.
mRNA advances raise manufacturing demands, but CDMO returns remain uncertain
News and articles
Healthcare & Pharma
Peptide Contract Manufacturing Market to reach US$12.88bn by 2036
13 October 2026.
The Peptide Contract Manufacturing market is projected to grow at a CAGR of 12.7% by 2036
Biopharmaceuticals Contract Manufacturing Market to reach US$69.11bn
11 October 2026.
The Biopharmaceuticals Contract Manufacturing market is projected to grow at a CAGR of 12.7% by 2036
Protein Contract Manufacturing Market to Reach US$33.62bn
10 October 2026.
Biologics outsourcing and demand for specialist manufacturing capacity are driving 9.7% CAGR through 2036.
CPHI Milan 2026 Day 3: Innovation Meets Commercial Reality
8 October 2026.
CPHI Milan examines what turns pharmaceutical innovation into commercial scale
CPHI Milan 2026 Day 2: Proof Over Promise
7 October 2026.
CPHI Milan tests manufacturing capability, execution, validation and proven performance
CPHI Milan 2026 Day 1: Manufacturing Moves Beyond Capacity
6 October 2026.
CPHI Milan highlights specialist capacity, resilient supply and scalable AI
mRNA Contract Manufacturing Market to reach US$13.52bn by 2036
5 October 2026.
The mRNA Contract Manufacturing market is projected to grow at a CAGR of 11.3% by 2036
CPHI Milan 2026: Pharma Manufacturing
CPHI Milan opens next week with manufacturing under growing scrutiny across the pharmaceutical industry
Clinical Trial Infrastructure Moves Centre Stage
23 September 2026.
Clinical trials are getting harder to run as complexity increases
Pharma’s Capacity Illusion
15 September 2026.
Specialist pharma capacity remains constrained by format, qualification and demand
Antibody Drug Conjugates Market to Reach US$55.94bn
12 September 2026.
The global Antibody Drug Conjugates market is projected to grow at a CAGR of 11.8% by 2036
Antibody Drug Conjugates Contract Manufacturing Market to reach US$6.31bn by 2036
9 September 2026.
The global Antibody Drug Conjugates Contract Manufacturing market is projected to grow at a CAGR of 11.4% by 2036
Pharma’s Manufacturing Reshuffle Is Feeding CDMO Growth
9 September 2026.
Commercial site transfers reshape CDMO growth, revenue timing and value
Clinical Trial Supply and Logistics Market for Pharma to reach US$18.22bn
4 September 2026.
The global Clinical Trial Supply and Logistics Market for Pharma is projected to grow at a CAGR of 8.7% by 2036
Faster Clinical Trials Test Pharma’s Supply Chains
2 September 2026.
Faster trials increase demand for flexible, resilient clinical supply networks
Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market to reach US$29.47bn
1 September 2026.
The global Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 9.0% by 2036
US Pharma’s Manufacturing Boom: Who Wins?
26 August 2026.
US pharma investment shifts toward strategic, complex, domestic manufacturing capacity
The CDMO Capacity Race Has Changed
18 August 2026.
CDMO competition shifts toward specialist capacity, geography and selective outsourcing
Can Moderna Make mRNA Work in Flu?
12 August 2026.
Moderna’s flu approval tests whether mRNA can deliver commercial scale
